Daniel Pereira-Sousa

Statistics

Publications

Citations

189

H-Index

Active since

2022

Affiliations

AstraZeneca (United Kingdom)(Current)

AstraZeneca (Sweden)

Woolcock Institute of Medical Research

Uppsala University

The University of Sydney

Daniel Pereira-Sousa is an author at AstraZeneca (United Kingdom) specializing in obstructive lung disease, chronic obstructive pulmonary disease, and pulmonology.

ORCID

Publications per year

2022–2024

Publications

Generation and maturation of human iPSC-derived 3D organotypic cardiac microtissues in long-term culture

Ece Ergir, Jorge Oliver‐De La Cruz, Soraia Fernandes et al. · Scientific Reports · 2022 · 90 citations · Full text

Life Sciences, Bioengineering, Cell Biology +15

Frequent productive cough: Symptom burden and future exacerbation risk among patients with asthma and/or COPD in the NOVELTY study

Rod Hughes, Eleni Rapsomaniki, Christer Janson et al. · Respiratory Medicine · 2022 · 44 citations · Full text

Medicine, Clinical Sciences, Internal Medicine +15

Chronic Airways Assessment Test: psychometric properties in patients with asthma and/or COPD

Erin Tomaszewski, Mark J. Atkinson, Niklas Karlsson et al. · Respiratory Research · 2023 · 23 citations · Full text

Medicine, Clinical Sciences, Differential Item Functioning +11

The burden of mild asthma: Clinical burden and healthcare resource utilisation in the NOVELTY study

Sarowar Golam, Christer Janson, Richard Beasley et al. · Respiratory Medicine · 2022 · 20 citations · Full text

Medicine, Internal Medicine, Primary Care +16

Fibrotic extracellular matrix impacts cardiomyocyte phenotype and function in an iPSC-derived isogenic model of cardiac fibrosis

Francesco Niro, Soraia Fernandes, Marco Cassani et al. · Translational research · 2024 · 12 citations · Full text

Life Sciences, Cardiology, Cell Biology +17

1–5 of 5